A recent blood-based hepatitis C virus assay on Nuclein's DASH system highlighted its on-device sample prep, among other features that have been driving its adoption.

LOS ANGELES--(BUSINESS WIRE)--Molecular Instruments® (MI), the inventor of the HCR™ platform, today announced key enhancements to its HCR™ Gold and HCR™ Pro product lines. These upgrades include ...

Panelists stress that timely and accurate diagnosis of KMT2A-rearranged acute myeloid leukemia (AML) is essential for personalized treatment planning, highlighting the need to overcome systemic delays ...

The Eonis™ Q system from Revvity is an innovative dry PCR workflow that simplifies and streamlines molecular testing for SMA and SCID. It comprises the compact Eonis™ Q96 instrument, stable and ...

High Efficiency means low-cost, easy-to-use molecular testing under $20 per test with no sample preparation required. 3EO announces the availability of no charge ...

Advancing next-generation IMC workflows with class-leading HCR imaging technologies for greater sensitivity and flexibility The partnership combines HCR Gold for RNA and protein imaging with the ...

Harrisburg, NC---- 10/21/2020-- The Molecular Diagnostics Devices And Equipment Market report is a valuable source of insightful data for business strategists. The global molecular diagnostics devices ...

Molecular Instruments, Inc. announced today that the Unified Patent Court (UPC) of the European Union has found that Molecular Instruments’ HCR™ RNA-ISH technology does not infringe two patents owned ...

Please provide your email address to receive an email when new articles are posted on . Thyroid nodules are common. Each year, approximately 600,000 U.S. residents with nodules undergo a fine-needle ...